HUP0103856A3
(en )
2003-11-28
Pharmaceutical composition for the treatment of acute disorders
HUP0104676A3
(en )
2005-12-28
Compositions for the treatment of anorectal disorders and their use
IL125735A0
(en )
1999-04-11
Pharmaceutical compositions for the treatment of glaucoma
IL138129A
(en )
2005-06-19
Composition for therapy of estrogen-associated disorders
GB2311940B
(en )
2000-07-19
Pharmaceutical compositions for the treatment of rhinitis
HUP0200287A3
(en )
2002-12-28
Pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders
ZA9811629B
(en )
2000-06-19
The use of MMP inhibitors for the treatment of ocular angiogenesis.
HUP0201791A3
(en )
2005-02-28
The use of escitalopram for treatment of neurotic disorders
PL345769A1
(en )
2002-01-02
Triazolopyridines for the treatment of thrombosis disorders
GB9816234D0
(en )
1998-09-23
Compounds for use in the treatment of inflammation
HUP0101947A3
(en )
2001-12-28
Combination for the treatment of tumors
ZA978640B
(en )
1998-03-27
Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
EP0679397A3
(en )
1996-07-17
Use of substituted amines for the treatment of cerebral insufficiencies.
CZ20011872A3
(en )
2002-03-13
Isonipecotamides for the treatment of integrin-mediated disorders
IL140540A0
(en )
2002-02-10
Treatment of anxiety disorders
HUP0100365A3
(en )
2002-06-28
Combination therapy for the treatment of aids
SG82014A1
(en )
2001-07-24
The use of aryl-cyclohexylamine derivatives against cns disorders
SI1069900T1
(en )
2005-12-31
Use of reboxetine for the treatment of neuropsychiatric disorders
PT1011678E
(en )
2008-02-07
Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
GB9904252D0
(en )
1999-04-21
Composition for the treatment of pain
AU2215099A
(en )
1999-07-26
Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
GB2341099B
(en )
2001-08-08
Clinical table for treatment of the spine
GB9821610D0
(en )
1998-11-25
Treatment of neuropsychiatric disorders
GB9923551D0
(en )
1999-12-08
Treatment of neuropsychiatric disorders
GB2354946B
(en )
2001-05-16
Means for the treatment of prion disease